Colistin forKlebsiella pneumoniae–Associated Sepsis | Zendy

Andreas Karabinis | Zendy; E. Paramythiotou | Zendy; Dimitra Mylona-Petropoulou | Zendy; Alexandros Kalogeromitros | Zendy; N Katsarelis | Zendy; Flora Kontopidou | Zendy; Ioannis Poularas | Zendy; H. MalamouLada | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Colistin forKlebsiella pneumoniae–Associated Sepsis

Author(s) -

Andreas Karabinis,

E. Paramythiotou,

Dimitra Mylona-Petropoulou,

Alexandros Kalogeromitros,

N Katsarelis,

Flora Kontopidou,

Ioannis Poularas,

H. MalamouLada

Publication year - 2003

Publication title -

clinical infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/380461

Subject(s) - colistin , klebsiella pneumoniae , medicine , imipenem , antibiotics , microbiology and biotechnology , septic shock , sepsis , intensive care unit , minimum inhibitory concentration , intensive care medicine , antibiotic resistance , biology , biochemistry , escherichia coli , gene

Klebsiella pneumoniae that was resistant to all available antibiotics (minimum inhibitory concentration of imipenem, 32 microg/mL), including carbapenems, was isolated from blood samples obtained from a 48-year-old patient in the intensive care unit. The patient developed septic shock, which was successfully treated with colistin, the only antibiotic with activity against this multidrug-resistant strain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research